Peripheral chondrosarcoma progression is associated with increased type X collagen and vascularisation

Virchows Archiv

Volumn 460, Issue 1, 2012, Pages 95-102

  De Andrea, Carlos E ^a   Wiweger, Malgorzata I ^a   Bovée, Judith V M G ^a   Romeo, Salvatore ^b   Hogendoorn, Pancras C W ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b TREVISO REGIONAL HOSPITAL   (Italy)

Author keywords

Angiogenesis; Bone tumour; Growth plate; Osteochondroma; Peripheral chondrosarcoma; Type X collagen

Indexed keywords

COLLAGEN TYPE 10; EXT1 ENZYME; EXT2 ENZYME; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; ARTICULAR CARTILAGE; BLOOD VESSEL; CANCER INVASION; CANCER PATIENT; CARTILAGE CELL; CELL DENSITY; CELL DIFFERENTIATION; CHILD; CHONDROSARCOMA; CLINICAL ARTICLE; CONTROLLED STUDY; ENCHONDRAL OSSIFICATION; EPIPHYSIS PLATE; FEMALE; GENE EXPRESSION; GENE MUTATION; GERM LINE; HISTOPATHOLOGY; HOMOZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MUTATIONAL ANALYSIS; PERIPHERAL CHONDROSARCOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN FUNCTION; RISK FACTOR; SCHOOL CHILD; TUMOR GROWTH; TUMOR LOCALIZATION; VASCULARIZATION;

ADOLESCENT; ADULT; APOPTOSIS; BONE NEOPLASMS; CELL DIFFERENTIATION; CHILD; CHILD, PRESCHOOL; CHONDROCYTES; CHONDROSARCOMA; COLLAGEN TYPE X; DISEASE PROGRESSION; FEMALE; GROWTH PLATE; HUMANS; MALE; MIDDLE AGED; MUTATION; N-ACETYLGLUCOSAMINYLTRANSFERASES; NEOVASCULARIZATION, PATHOLOGIC; OSSIFICATION, HETEROTOPIC; OSTEOCHONDROMA; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84857045339     PISSN: 09456317     EISSN: 14322307     Source Type: Journal    
DOI: 10.1007/s00428-011-1168-9     Document Type: Article

References (28)

1. Kronenberg HM (2003) Developmental regulation of the growth plate. Nature 423:332-336 (Pubitemid 40852707)
2. Kuhn JL, DeLacey JH, Leenellett EE (1996) Relationship between bone growth rate and hypertrophic chondrocyte volume in New Zealand white rabbits of varying ages. J Orthop Res 14:706-711 (Pubitemid 26376513)
3. Ballock RT, O'Keefe RJ (2003) The biology of the growth plate. J Bone Joint Surg Am 85-A:715-726
4. Aigner T, Frischolz S, Dertinger S, Beier F, Girkontaité I, Von der Mark K (1997) Type X collagen expression and hypertrophic differentiation in chondrogenic neoplasias. Histochem Cell Biol 107:435-440 (Pubitemid 27306972)
5. Khurana J, Abdul-Karim F (2002) Bovée JVMG Osteochondroma. In: Fletcher CDM, Unni KK, Mertens F (eds) World Health Organization classification of tumours. Pathology and genetics of tumours of soft tissue and bone. IARC Press, Lyon (France), pp 234-236
6. van den Berg H, Kroon HM, Slaar A, Hogendoorn P (2008) Incidence of biopsy-proven bone tumors in children: a report based on the Dutch pathology registration "PALGA". J Pediatr Orthop 28(1):29-35 (Pubitemid 351628188)
7. Bovee JVMG, Hogendoorn PCW, Wunder JS, Alman BA (2010) Cartilage tumours and bone development: molecular pathology and possible therapeutic targets. Nat Rev Cancer 10:481-488
8. Dorfman HD, Czerniak B, Kotz R, Vanel D, Park YK, Unni KK (2002) WHO classification of tumours of bone: introduction. In: Fletcher CDM, Unni KK, Mertens F (eds) World Health Organization classification of tumours. Pathology and genetics of tumours of soft tissue and bone. IARC Press, Lyon, pp 226- 232
9. de Andrea CE, Reijnders CM, Kroon HM, de Jong D, Hogendoorn PC, Szuhai K et al (2011) Secondary peripheral chondrosarcoma evolving from osteochondroma as a result of outgrowth of cells with functional EXT. Oncogene. doi:10.1038/onc.2011.311
10. Kucharzewska P, Welch JE, Birgersson J, Belting M (2010) Establishment of heparan sulphate deficient primary endothelial cells from EXT-1(flox/flox) mouse lungs and sprouting aortas. In Vitro Cell Dev Biol Anim 46:577-584
11. Hilton MJ, Gutierrez L, Martinez DA, Wells DE (2005) EXT1 regulates chondrocyte proliferation and differentiation during endochondral bone development. Bone 36:379-386 (Pubitemid 40403836)
12. Wiweger MI, Avramut CM, de Andrea CE, Prins FA, Koster AJ, Ravelli RB et al (2011) Cartilage ultrastructure in proteoglycan-deficient zebrafish mutants brings to light new candidate genes for human skeletal disorders. J Pathol 223:531-542
13. Hufnagel L, Kreuger J, Cohen SM, Shraiman BI (2006) On the role of glypicans in the process of morphogen gradient formation. Dev Biol 300:512-522 (Pubitemid 44909107)
14. Hacker U, Nybakken K, Perrimon N (2005) Heparan sulphate proteoglycans: the sweet side of development. Nat Rev Mol Cell Biol 6:530-541 (Pubitemid 40943044)
15. Reijnders CM, Waaijer CJ, Hamilton A, Buddingh' EP, Dijkstra SP, Ham J et al (2010) No haploinsufficiency but loss of heterozygosity for EXT in multiple osteochondromas. Am J Pathol 177:1946-1957
16. Verbeke SL, Fletcher CD, Alberghini M, Daugaard S, Flanagan AM, Parratt T et al (2010) A reappraisal of hemangiopericytoma of bone; analysis of cases reclassified as synovial sarcoma and solitary fibrous tumor of bone. Am J Surg Pathol 34:777-783
17. Schrage YM, Machado I, Meijer D, Briaire-de Bruijn I, van den Akker B, Taminiau AHM et al (2010) COX-2 expression in chondrosarcoma: a role for celecoxib treatment? Eur J Cancer 46:616-624
18. de Andrea CE, Wiweger M, Prins F, Bovee JVMG, Romeo S, Hogendoorn PCW (2010) Primary cilia organization reflects polarity in the growth plate and implies loss of polarity and mosaicism in osteochondroma. Lab Invest 90:1091-1101
19. Vermeulen PB, Gasparini G, Fox SB, Toi M, Martin L, McCulloch P et al (1996) Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation. Eur J Cancer 32A:2474-2484
20. Hansen S, Grabau DA, Sorensen FB, Bak M, Vach W, Rose C (2000) The prognostic value of angiogenesis by Chalkley counting in a confirmatory study design on 836 breast cancer patients. Clin Cancer Res 6:139-146 (Pubitemid 30064986)
21. Vink GR, White SJ, Gabelic S, Hogendoorn PCW, Breuning MH, Bakker E (2004) Mutation screening of EXT1 and EXT2 by direct sequence analysis and MLPA in patients with multiple osteochondromas: splice site mutations and exonic deletions account for more than half of the mutations. Eur J Hum Genet 13:470-474 (Pubitemid 40520938)
22. White SJ, Vink GR, Kriek M, Wuyts W, Schouten J, Bakker B et al (2004) Two-color multiplex ligation-dependent probe amplification: detecting genomic rearrangements in hereditary multiple exostoses. Hum Mutat 24:86-92 (Pubitemid 38859227)
23. Bovee JVMG, Cleton-Jansen AM, Wuyts W, Caethoven G, Taminiau AHM, Bakker E et al (1999) EXT-mutation analysis and loss of heterozygosity in sporadic and hereditary osteochondromas and secondary chondrosarcomas. Am J Hum Genet 65:689-698 (Pubitemid 30468713)
24. Hameetman L, David G, Yavas A, White SJ, Taminiau AHM, Cleton-Jansen AM et al (2007) Decreased EXT expression and intracellular accumulation of HSPG in osteochondromas and peripheral chondrosarcomas. J Pathol 211:399-409 (Pubitemid 46332551)
25. Koziel L, Kunath M, Kelly OG, Vortkamp A (2004) EXT1- dependent heparan sulfate regulates the range of Ihh signaling during endochondral ossification. Dev Cell 6:801-813 (Pubitemid 38745415)
26. Iozzo RV (2001) Heparan sulfate proteoglycans: intricate molecules with intriguing functions. J Clin Invest 108:165-167 (Pubitemid 32656237)
27. Bernfield M, Gotte M, Park PW, Reizes O, Fitzgerald ML, Lincecum J et al (1999) Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 68:729-777 (Pubitemid 29449208)
28. Chen E, Hermanson S, Ekker SC (2004) Syndecan-2 is essential for angiogenic sprouting during zebrafish development. Blood 103:1710-1719 (Pubitemid 38268963)